Y-6 sublingual tablet for small deep strokes
Part of Brain & nervous system clinical trials.
This study tests a new tablet (Y-6), placed under the tongue, for treating a small, deep stroke. It aims to help people recover better if given within 72 hours of symptoms starting and without severe artery blockages or bleeding risks.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You had a small, deep stroke in a tiny artery inside your brain.
- You are between 18 and 80 years old.
- You start the study treatment within 72 hours of your first symptoms.
- You have no severe blockages in the main artery that supplies blood to the stroke area.
- You are not at high risk for bleeding or taking strong blood thinners.
- You have not had bleeding in the brain or major surgery recently.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This trial tests a new sublingual tablet (Edaravone Dexborneol) to help people recover after a small stroke caused by disease of the small blood vessels in the brain. It aims to see if the drug can improve thinking and daily function.
This trial tests an investigational drug called B2065 for people who have had a recent ischemic stroke (a stroke caused by a blockage in a blood vessel in the brain). The goal is to see if it is safe and if it might help improve recovery when given within 36 hours of stroke symptoms starting.
This trial tests an investigational injection called KPCXM18 for people having an acute ischemic stroke. It is given within 12 hours of symptom onset, in addition to standard clot-dissolving treatment, to see if it improves recovery and safety.
This trial looks at whether using an MRI blood-flow (perfusion) scan to help choose treatment improves outcomes for certain large-vessel strokes. You must be treated within 6–24 hours after symptoms start, with specific scan and blood test findings.
This trial tests an investigational sublingual tablet called Y-6 for people having an acute ischemic stroke (a stroke caused by a clot). It may help improve recovery when given within 24 hours of stroke onset, alongside standard endovascular treatment to remove the clot.
This trial tests whether XY03-EA tablets can help people recover after an acute ischemic stroke. Participants must have had a stroke within the last 48 hours and have moderate to severe symptoms but not be in a coma.
Hear when a new Perforating Artery Infarction trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.